PubRank

Patrick Honeck

Author PubWeight™ 13.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol 2007 1.79
2 Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 2008 1.40
3 Unfavorable outcomes of laparoscopic pyeloplasty using barbed sutures: a multi-center experience. World J Urol 2013 1.37
4 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 2010 1.29
5 Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study. J Endourol 2010 1.09
6 Flexible ureterorenoscopy for lower pole stones: influence of the collecting system's anatomy. J Endourol 2013 1.04
7 A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol 2007 1.02
8 Flexible ureterorenoscopy versus miniaturized PNL for solitary renal calculi of 10-30 mm size. World J Urol 2011 0.90
9 Conventional high pressure versus newly developed continuous-flow ureterorenoscope: urodynamic pressure evaluation of the renal pelvis and flow capacity. J Endourol 2008 0.85
10 Percutaneous nephrolithotomy under combined sonographic/radiologic guided puncture: results of a learning curve using the modified Clavien grading system. World J Urol 2013 0.81
11 Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines. Urology 2007 0.80
12 Topical chemotherapy in human urothelial carcinoma explants: a novel translational tool for preclinical evaluation of experimental intravesical therapies. Eur Urol 2008 0.77
13 Correlation between motor function and lower urinary tract dysfunction in patients with infantile cerebral palsy. Neurourol Urodyn 2007 0.76
14 Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma. Anal Quant Cytol Histol 2008 0.75
15 [Botulinum toxin injection for neurogenic and no neurogenic bladder dysfunction]. Arch Esp Urol 2005 0.75